From the bluetongue vaccination campaigns in sheep to overimmunization and ovine ASIA syndrome
Immunologic Research, ISSN: 1559-0755, Vol: 66, Issue: 6, Page: 777-782
2018
- 7Citations
- 25Captures
- 2Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations7
- Citation Indexes7
- CrossRef7
- Captures25
- Readers25
- 25
- Mentions2
- News Mentions2
- News2
Most Recent News
Americans can handle an open discussion about vaccines: RFK. Jr's response to criticism from his family that Politico would not publish
In early May 2019, Politico Magazine published an article written by three of Robert F. Kennedy, Jr.'s relatives, criticizing his advocacy for safe vaccines. After numerous requests, Politico magazine has refused to publish his response. Three of my Kennedy relatives recently published an article criticizing my advocacy for safe vaccines. Our contentious family dispute highlights the fierce nation
Article Description
The use of vaccines has proven to be very effective in controlling and eradicating infectious diseases, both in veterinary and human medicine; however, vaccines can be also the source of an array of problems caused by procedures such as overimmunization. Bluetongue, an orbiviral disease that affects ruminants, is best controlled by the use of inactivated vaccines. During the last years of the past decade, these vaccines were applied all over Europe to control the spreading of the disease, a goal that was accomplished; however, at the same time, several adverse effects related to the vaccination were reported. Especially in sheep, this vaccination campaign brought out a new cachectic and neurologic disease with harmful consequences for the ovine industry. This disease is now recognized as the ovine version of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA syndrome) and poses an immense challenge in veterinary medicine, immunology, and vaccinology.[Figure not available: see fulltext.].
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85059855998&origin=inward; http://dx.doi.org/10.1007/s12026-018-9059-7; http://www.ncbi.nlm.nih.gov/pubmed/30632098; http://link.springer.com/10.1007/s12026-018-9059-7; https://dx.doi.org/10.1007/s12026-018-9059-7; https://link.springer.com/article/10.1007/s12026-018-9059-7
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know